New Anxiety Disorders Study Results Reported from Barrow Neurological Institute (Brain Regional Glucose Metabolism, Neuropsy-chiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: the Mayo Clinic Study of Aging)

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily- Research findings on Mental Health Diseases and Conditions - Anxiety Disorders are discussed in a new report. According to news reporting out of Phoenix, Arizona, by NewsRx editors, the research stated, "The authors conducted a prospective cohort study to examine the risk of incident mild cognitive impairment (MCI) as predicted by baseline neuropsychiatric symptoms (NPS) and brain regional glucose metabolic dysfunction. About 1,363 cognitively unimpaired individuals (52.8% males) aged >= 50 years were followed for a median of 4.8 years to the outcome of incident MCI." Financial supporters for this research include NIH grant: National Institute on Aging, NIH grant: National Institute of Mental Health, NIH National Institute of Neurological Disorders & Stroke (NINDS), Robert Wood Johnson Foundation (RWJF), GHR Foundation, Mayo Foundation for Medical Education and Research, National Program of Sustainability II (MEYS CR), Edli Foundation.